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https://doi.org/10.1016/j.hpb.2018.02.378 HPBORIGINAL ARTICLEMyosteatosis predicts survival after surgery for
periampullary cancer: a novel method using MRI
David P.J. van Dijk1,2, Frans C.H. Bakers3, Sebastian Sanduleanu3, Rianne D.W. Vaes1,2,
Sander S. Rensen1,2, Cornelis H.C. Dejong1,2,4,5, Regina G.H. Beets-Tan5,6 &
Steven W.M. Olde Damink1,2,4
1Department of Surgery, Maastricht University Medical Centre, Maastricht, 2NUTRIM School of Nutrition and Translational Research in
Metabolism, Maastricht University, 3Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht,
The Netherlands, 4Department of General, Visceral and Transplantation Surgery, RWTH University Hospital Aachen, Aachen, Germany,
5GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, and 6Department of Radiology,
Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The NetherlandsAbstract
Background: Myosteatosis, characterized by inter- and intramyocellular fat deposition, is strongly
related to poor overall survival after surgery for periampullary cancer. It is commonly assessed by
calculating the muscle radiation attenuation on computed tomography (CT) scans. However, since
magnetic resonance imaging (MRI) is replacing CT in routine diagnostic work-up, developing methods
based on MRI is important. We developed a new method using MRI-muscle signal intensity to assess
myosteatosis and compared it with CT-muscle radiation attenuation.
Methods: Patients were selected from a prospective cohort of 236 surgical patients with periampullary
cancer. The MRI-muscle signal intensity and CT-muscle radiation attenuation were assessed at the level
of the third lumbar vertebra and related to survival.
Results: Forty-seven patients were included in the study. Inter-observer variability for MRI assessment
was low (R2 = 0.94). MRI-muscle signal intensity was associated with short survival: median survival 9.8
(95%-CI: 1.5–18.1) vs. 18.2 (95%-CI: 10.7–25.8) months for high vs. low intensity, respectively
(p = 0.038). Similar results were found for CT-muscle radiation attenuation (low vs. high radiation
attenuation: 10.8 (95%-CI: 8.5–13.1) vs. 15.9 (95%-CI: 10.2–21.7) months, respectively; p = 0.046). MRI-
signal intensity correlated negatively with CT-radiation attenuation (r=−0.614, p < 0.001).
Conclusions: Myosteatosis may be adequately assessed using either MRI-muscle signal intensity or
CT-muscle radiation attenuation.Received 18 September 2017; accepted 4 February 2018Correspondence
David P.J. van Dijk, Universiteitssingel 50, 6229 ER, Maastricht, The Netherlands. E-mail: d.vandijk@
maastrichtuniversity.nlBackground
The use of single slice computed tomography (CT) imaging for
risk assessment has become increasingly popular for various
types of diseases.1,2 A single CT-slide can be used to estimate
total body amounts of skeletal muscle, visceral adipose tissue,
and subcutaneous adipose tissue.3 Next to body-composition,
CT-scans provide additional information, such as the muscleFunding: This work was partly funded by the Netherlands Organization for
Scientific Research (NWO Grant 022.003.011).
HPB 2018, 20, 715–720 © 2018 International Hepato-Pradiation attenuation or muscle radio density: the average
Hounsfield unit value of the skeletal muscle tissue at the L3
level.4 Low muscle radiation attenuation is a sign of myostea-
tosis, a condition associated with poor survival in various types
of cancer.1 We previously found a strong association between
myosteatosis and overall survival in multivariate analysis in
patients with periampullary cancer.5 Myosteatosis has been
associated with a systemic inflammatory response in cancer
patients,6,7 which could be related to cancer cachexia, a syn-
drome of severe weight loss and muscle wasting.8 The possibleancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
716 HPBlink with cancer cachexia might be an explanation for the strong
survival effect of myosteatosis. Although mostly CT-scans are
used for assessment of myosteatosis, magnetic resonance im-
aging (MRI) provides higher contrast for soft tissue and could
therefore be superior to CT for visualizing soft tissue such as
skeletal muscle. However, to our knowledge there are no studies
assessing myosteatosis using MRI-scans. Developing MRI-
based methods is important since MRI-scans are increasingly
used in routine diagnostic work-up and follow-up of (peri-
ampullary) cancer, sometimes even replacing CT-scans.9,10 In
this study, we compared MRI muscle signal intensity with CT
muscle radiation attenuation as markers of myosteatosis and
assessed the association of both markers with overall survival in
patients with periampullary cancer undergoing pancreatic
surgery.Methods
Subjects
A prospective cohort of 236 patients undergoing pancreatic
surgery between 2008 and 2014 at the Maastricht University
Medical Centre (MUMC), the Netherlands was studied. From
this cohort, one hundred and eighty-six patients have been re-
ported on before in the context of the relationship between
myosteatosis and overall survival using CT imaging alone.5 Pa-
tients were included for analysis if they had pathology-proven or
radiology-proven periampullary cancer and both a preoperative
CT-scan and MRI-scan available (<2 months before surgery).
Exclusion criteria were the presence of a neuro-endocrine tumor,
benign disease, or pre-malignant disease (such as intraductal
papillary mucinous neoplasm).
Data collection
The primary outcome parameter of this study was overall sur-
vival, measured in months from the day of surgery. Secondary
outcome was the correlation between CT muscle radiation
attenuation in HUs and MRI muscle signal intensity. Patient-
reported weight, height, and weight loss in the six months
prior to surgery as well as age and sex were recorded at the
outpatient department. Comorbidities (diabetes mellitus, car-
diac, pulmonary, and/or renal disorders) were retrieved from the
patient’s medical file. The most important severe post-operative
complications, which are included in the pancreaticoduodenec-
tomy composite endpoint (Dindo-Clavien grade  3),11 were
recorded postoperatively until 90 days after surgery. These
included intra-abdominal abscess, sepsis, gastrojejunostomy
leakage, post-pancreaticoduodenectomy hemorrhage, bile
leakage/hepaticojejunostomy leakage, pancreatic fistula/pancre-
atic anastomosis leakage, delayed gastric emptying, and mortal-
ity. Definitive diagnosis and tumor staging were based on the
pathology report of the resected specimen. The study protocol
was approved by the medical ethical committee of the MUMC
which waived the requirement to obtain informed consent.HPB 2018, 20, 715–720 © 2018 International Hepato-PImage analysis
Abdominal CT-scans and MRI-scans were analyzed in anony-
mized format. Two blinded researchers trained in radiologic
anatomy and body composition analysis (DvD and FB) evaluated
the MRI-scans independently. CT-scans were evaluated by DvD
alone, as CT-body composition analysis has been validated
before.1,3 First, a single slice of each patient’s CT-scan and MRI-
scan was selected at the level of the third lumbar vertebra (L3).
For MRI-scans, only T2 weighted images were selected. When
multiple slices at L3 were available, the slice on which both
transverse processes were best visible was selected. CT-scans and
MRI-scans were all screened before analysis by an abdominal
radiologist for poor quality and large radiation artifacts, or if
parts of muscle tissue were not visualized on the dorsal or both
lateral edges. These scans were excluded from analysis. Since
many MRI-scans suffered from radiological artifacts on the
ventral side, only the dorsal portion of the muscles (at the ventral
border of the body of the L3 vertebra) was analyzed for both CT
and MRI-scans (see Fig. 1). Scans were analyzed using sliceO-
matic 5. (TomoVision, Magog, Canada) software for Microsoft
Windows®. Myosteatosis was defined as a low CT muscle radia-
tion attenuation or a high MRI muscle signal intensity. For CT-
images, the cross-sectional area (cm2) of the dorsal skeletal
muscles was measured including intermuscular adipose tissue
(IMAT). The muscle radiation attenuation was assessed by
calculating the average HU value of the total muscle area. The
same was done for MRI-images, but instead of average HU value,
the average signal intensity of the total muscle area was calcu-
lated. Since signal intensity is scaled per acquired sequence, the
measured intensity cannot be compared within or between pa-
tients, making normalization against an internal standard
necessary. Therefore, we normalized muscle signal intensity
using the cerebrospinal fluid signal (CSF) intensity. The rationale
behind this approach is based on the similarity of the signal
intensity of CSF and water, the availability of CSF within L3
slides, and the assumed stable relation between muscle and CSF
signal intensity within a single patient. Normalization with CSF
signal intensity had therefore high potential to correct for signal
intensity differences among different scan sessions and patients.
Cerebrospinal fluid signal intensity was calculated for the total
visible area of CSF (excluding any nervous tissue) at the same
level as the skeletal muscle assessment (L3). The average values of
the two observers’ MRI measurements were used for analysis.
Statistical analysis
Since there are no published cut-offs for MRI muscle signal in-
tensity and our cohort was too small for cut point analysis by
optimal stratification,12 we determined sex-specific cut-off values
based on tertiles, which is a common method for small co-
horts.5,13 Cut-off values were set at the lowest tertile for muscle
radiation attenuation and at the highest tertile for MRI muscle
signal intensity. Data were analyzed using IBM SPSS 23 for
Microsoft Windows®. Inter-observer variability was assessedancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
Figure 1 MRI (a) and CT (b) annotations for skeletal muscle analysis. The dorsal portion of total muscle tissue was annotated at L3 level (red). For
MRI (a), the average signal intensity was calculated and corrected for cerebrospinal fluid signal intensity. For CT (b), the average Hounsfield units
value was calculated (radiation attenuation). CT = computed tomography, MRI = magnetic resonance imaging
Table 1 Patient characteristics
Patients (n [ 47)
Age (years) 67.4 ± 10.7
Male (n, %) 24 (51.1%)
BMI (kg/m2) 24.8 ± 4.1
Pathology (n, %)
Pancreatic 19 (40.4%)
HPB 717using linear regression and by calculating the root mean square
of coefficients of variation. Cohen’s kappa (k) was used to
indicate the inter-observer agreement of high vs. low MRI
muscle signal intensity. The Kaplan Meier estimate was used to
assess the association of muscle radiation attenuation and muscle
signal intensity with survival. The reverse Kaplan–Meier esti-
mate was used to estimate the median follow-up time. For cor-
relation, Pearson’s correlation coefficient (r) was used. A p-value
of <0.05 was considered significant.Ampullary 12 (25.5%)
Cholangiocarcinoma 4 (8.5%)
Other 2 (4.2%)
None available (palliative surgery) 10 (21.3%)
Comorbidity (n, %)
Diabetes mellitus 10 (21.3%)
Cardiac 17 (36.3%)
Pulmonary 5 (10.6%)
Renal 2 (4.3%)
Postoperative complicationsa (n, %) 19 (40.4%)
Patient characteristics of the study cohort. Continuous variables are
shown as mean ± standard deviation.
a Patients had one or more of the following complications: Intra-
abdominal abscess, sepsis, gastrojejunostomy leakage, post-
pancreaticoduodenectomy hemorrhage, bile leakage, pancreatic
fistula, delayed gastric emptying, or operative mortality (within 90
days after surgery).Results
Patient cohort
From all 236 patients of the prospective cohort, 55 patients had
both a CT-scan and MRI-scan available. Eight patients were
excluded because of IPMN (n = 4) or benign disease (n = 4),
resulting in a final number of 47 patients included into this study.
Median follow-up was 59.8 months. Patient characteristics are
shown in Table 1.
Image analysis
After scoring for quality, two CT-scans and two MRI-scans were
scored as poor and therefore excluded from the analysis. The
inter-observer variability of the MRI assessments was low
(R2 = 0.94, root mean square of coefficients of variation = 4.4%;
see Fig. 2). Mean and sex-specific cut-offs are given in Table 2.
Myosteatosis was defined as a muscle radiation attenuation of
<27.0 HU (males) and <17.5 HU (females) or as a corrected MRI
muscle signal intensity of >0.33 (males) and >0.36 (females).
Inter-observer agreement was high (k = 0.90, p < 0.001). There
were no significant differences in patient characteristics between
patients with low vs. moderate-high CT radiation attenuation or
between patients with high vs moderate-lowMRI signal intensity
(p > 0.05 for all characteristics listed in Table 1). Without
correction for CSF signal intensity, MRI muscle signal intensity
did not correlate with CT muscle radiation attenuationHPB 2018, 20, 715–720 © 2018 International Hepato-P(r = −0.055, p = 0.727). After correction for CSF signal intensity,
MRI muscle signal intensity was inversely correlated with CT
muscle radiation attenuation (r = −0.614, p = <0.001; see Fig. 3).
Survival analysis
Survival analysis was performed for CT and MRI assessments
separately using the Kaplan–Meier estimate. Patients with low
CT muscle radiation attenuation had a lower survival than pa-
tients with moderate to high radiation attenuation: medianancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
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Figure 2 Inter-observer variability of MRI muscle signal intensity MRI
muscle signal intensity inter-observer variability was low (R2 = 0.94,
root mean square of coefficients of variation = 4.4%) MRI muscle
signal intensity was corrected for cerebrospinal fluid signal intensity.
MRI = magnetic resonance imaging
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Figure 3 Correlation between CT muscle radiation attenuation and
MRI muscle signal intensity. CT muscle radiation attenuation was
inversely correlated with MRI muscle signal intensity (r = −0.614,
p < 0.001). MRI muscle signal intensity was corrected for cerebrospinal
fluid signal intensity. CT = computed tomography, MRI = magnetic
resonance imaging
718 HPBsurvival 10.8 (95%-CI: 8.5–13.1) vs. 15.9 (95%-CI: 10.2–21.7)
months, respectively (p = 0.046; see Fig. 4). Patients with high
MRI muscle signal intensity had lower survival than patients
with moderate to low signal intensity: median survival 9.8 (95%-
CI: 1.5–18.1) vs. 18.2 (95%-CI: 10.7–25.8) months, respectively
(p = 0.038; see Fig. 4).Discussion
This study demonstrates that myosteatosis, reflected by either
low CTmuscle radiation attenuation or high MRI muscle signal
intensity, is associated with reduced survival in patients with
periampullary cancer. This is the first study describing a method
to quantify myosteatosis using MRI scans. Myosteatosis is an
important predictor of overall survival in patients with peri-
ampullary cancer5,6,14 and other cancers.1 Also, in benign disease
such as liver cirrhosis, myosteatosis has been associated withTable 2 Mean sex-specific cut-off values for CT muscle radiation atte
Male (n [ 24)
Mean (SD) Cut-o
Muscle radiation attenuation (HU) 27.0 (18.7) 27.0
Muscle signal intensity 0.28 (0.08) 0.33
Sex-specific cut-offs were made at the lower tertile for radiation attenua
considered to reflect ectopic fat accumulation in muscle tissue. Four sca
poor quality. MRI muscle signal intensity was corrected for cerebrospinal fl
CT = computed tomography, HU =Hounsfield unit, MRI = magnetic resona
HPB 2018, 20, 715–720 © 2018 International Hepato-Ppoor survival.2 Developing MRI-based methods to assess muscle
mass and fat content is important since MRI-scans increasingly
replace CT-scans in the diagnostic work-up of various malig-
nancies. Moreover, many benign diseases only use MRI-scans for
diagnosis or follow-up (e.g. inflammatory bowel disease).
Shen et al. previously showed that MRI based measurements
of skeletal muscle mass correlated well with CT-based mea-
surements of skeletal muscle mass.15 In the present study, we
demonstrate that MRI muscle signal intensity should be
normalized using CSF signal intensity to achieve an acceptable
correlation with CT-scan muscle radiation attenuation. The few
previous MRI based studies on myosteatosis only assessed
IMAT,16–23 which is visible adipose tissue in between the muscle
tissue rather than steatosis of the muscle tissue itself.4 Methods
assessing IMAT area vary greatly among studies: some studies
only measure anatomically visible IMAT area,16,17 while others
identify all tissue with a MRI signal intensity 20% lower than the
subcutaneous adipose tissue signal intensity as IMAT.18,19
Although these methods could be adequate for rough IMAT es-
timations, the cut-offs used for IMAT delineation are arbitrary.
Subcutaneous adipose tissue signal intensity is affected by itsnuation and MRI muscle signal intensity
Female (n [ 23) Total (n [ 47)
ff Mean (SD) Cut-off Mean (SD)
23.3 (13.7) 17.5 25.2 (16.3)
0.32 (0.07) 0.36 0.30 (0.07)
tion and at the higher tertile for MRI signal intensity, which both are
ns (two CT-scans and two MRI-scans) were not included because of
uid signal intensity.
nce imaging, SD = standard deviation.
ancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
Figure 4 Association between overall survival and high MRI muscle signal intensity/low CT muscle radiation attenuation. MRI muscle signal
intensity and low CT muscle radiation attenuation showed a similar negative association with survival. MRI muscle signal intensity was corrected
for cerebrospinal fluid signal intensity. CT = computed tomography, MRI = magnetic resonance imaging
HPB 719triglyceride content and therefore not a stable internal correction
factor. Some studies choose for a more objective approach by
producing histograms and dividing the tissue into areas with
high (IMAT) and low (muscle) signal intensity,20 mostly by
automatic segmentation.21–23 However, IMAT distribution is
highly heterogeneous among different muscles and slices. While
single L3 slice estimations of skeletal muscle, visceral adipose
tissue, and subcutaneous adipose tissue correlate well with total
body volumes,24 IMAT does not.25 Therefore, IMAT should be
assessed using total body scans instead of single L3 slices.25
In the present study, we assessed myosteatosis as an increase of
intramyocellular lipid content rather than increased IMAT in
between the muscle tissue. Stephens et al. previously showed that
the amount and size of intramyocellular lipid droplets were
inversely correlated with CT muscle radiation attenuation.26
Moreover, the amount of intramyocellular lipid droplets
increased with progression of cachexia. We therefore recommend
assessing indices of muscle lipid content rather than IMAT as
markers of myosteatosis.
There are some limitations to this study. The MRI images
used were targeted towards diagnosis of periampullary cancer
rather than muscle analysis. Since this is the first report vali-
dating MRI for assessing myosteatosis, the ideal scan settings
should be the focus of future research. Also, IMATwas included
in the signal intensity assessments. Ideally, IMAT should be
excluded from muscle analysis because of its heterogeneous
distribution, as described above. A combination of muscle
signal intensity assessment and internal correction by CSF
signal intensity as well as automatic segmentation to exclude
IMATwould be the best way forward. Unfortunately, our studyHPB 2018, 20, 715–720 © 2018 International Hepato-Pdid not include the gold standard muscle biopsy-based method
to assess performance statistics for CT and MRI. The moderate
to strong correlation between CT and MRI assessment of
myosteatosis suggests that both image modalities do not
necessarily replace each other. A larger study including a gold
standard method (e.g. triglyceride measurement on muscle
biopsies) should be conducted to prove the (external) validity of
measurements performed on CT and MRI studies. Lastly, our
study cohort was too small for multivariate analysis. However,
we previously demonstrated the association between CT-based
myosteatosis and overall survival using multivariate cox-
regression analysis.5
In conclusion, myosteatosis may be adequately assessed using
either CT muscle radiation attenuation or MRI muscle signal
intensity. MRI muscle signal intensity should be corrected for
CSF signal intensity as an internal standard. There was a strong
relationship between both CT- and MRI-based assessments of
myosteatosis and postoperative survival of patients with peri-
ampullary cancer. This novel MRI-based method can be useful
for risk assessment in patients without an available CT-scan, and
its use should be explored in risk assessment for diseases in which
exclusively MRI-scans are used in the diagnostic workup.
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